Self WK, Holtzman DM (2023) Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med 29:2187–2199
Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y (1994) High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145:452–460
PubMed PubMed Central Google Scholar
Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37:75–93
Jäkel L, De Kort AM, Klijn CJM, Schreuder FHBM, Verbeek MM (2022) Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimer’s Dement 18:10–28
Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ (2020) Cerebral amyloid angiopathy and Alzheimer disease—one peptide, two pathways. Nat Rev Neurol 16:30–42
Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GTAM, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1126
Bugiani O, Giaccone G, Rossi G, Mangieri M, Capobianco R, Morbin M, Mazzoleni R, Cupidi C, Marcon G, Giovagnoli A et al (2010) Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol 67:987–995
Jaunmuktane Z, Mead S, Ellis M, Wadsworth JD, Nicoll AJ, Kenny J, Launchbury F, Linehan J, Richard-Loendt A, Walker AS et al (2015) Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature 525:247–250
Jaunmuktane Z, Quaegebeur A, Taipa R, Viana-Baptista M, Barbosa R, Koriath C, Sciot R, Mead S, Brandner R (2018) Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery. Acta Neuropathol 135:671–679
Article PubMed PubMed Central Google Scholar
Kollmer M, Close W, Funk L, Rasmussen J, Bsoul A, Schierhorn A, Schmidt M, Sigurdson CJ, Jucker M, Fändrich M (2019) Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue. Nat Commun 10:4760
Article PubMed PubMed Central Google Scholar
Spina S, Farlow MR, Unverzagt FW, Kareken DA, Murrell JR, Fraser G, Epperson F, Crowther RA, Spillantini MG, Goedert M et al (2008) The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain 131:72–89
Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548
Yang Y, Arseni D, Zhang W, Huang M, Lövestam S, Schweighauser M, Kotecha A, Murzin AG, Peak-Chew SY, Macdonald J et al (2022) Cryo-EM structures of amyloid-β 42 filaments from human brains. Science 14:167–172
Annamalai K, Gührs KH, Koehler R, Schmidt M, Michel H, Loos C, Gaffney PM, Sigurdson CJ, Hegenbart U, Schönland S et al (2016) Polymorphism of amyloid fibrils in vivo. Angew Chem Int Ed 55:4822–4825
He S, Scheres SHW (2017) Helical reconstruction in RELION. J Struct Biol 198:163–176
Article PubMed PubMed Central Google Scholar
Zivanov J, Nakane T, Forsberg BO, Kimanius D, Wagen WJ, Lindahl E, Scheres SHW (2018) New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7:e42166
Article PubMed PubMed Central Google Scholar
Rohou A, Grigorieff N (2015) CTFFIND4: fast and accurate defocus estimation from electron micrographs. J Struct Biol 192:216–221
Article PubMed PubMed Central Google Scholar
Lövestam S, Li D, Wagstaff JL, Kotecha A, Kimanius D, McLaughlin SH, Murzin AG, Freund SMV, Goedert M, Scheres SHW (2023) Disease-specific tau filaments assemble via polymorphic intermediates. Nature. https://doi.org/10.1038/s41586-023-06788-w
Scheres SHW (2020) Amyloid structure determination in RELION-3.1. Acta Cryst D 76:94–101
Zivanov J, Otón J, Ke Z, von Kügelen A, Pyle E, Qu K, Morado D, Castaño-Diez D, Zanetti G, Bharat TAM et al (2022) A Bayesian approach to single-particle electron-tomography in RELION-4.0. eLife 11:e83724
Article PubMed PubMed Central Google Scholar
Scheres SHW, Chen S (2012) Prevention of overfitting in cryo-EM structure determination. Nat Methods 9:853–854
Article PubMed PubMed Central Google Scholar
Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D 66:486–501
Article PubMed PubMed Central Google Scholar
Yamashita K, Palmer CM, Burnley T, Murshudov GN (2021) Cryo-EM single particle structure refinement and map calculation using Servalcat. Acta Crystallogr D 77:1282–1291
Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D 53:240–255
Murshudov GN, Skubák P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA (2011) REFMAC for the refinement of macromolecular crystal structures. Acta Crystallogr D 67:355–367
Article PubMed PubMed Central Google Scholar
Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Ksaprai GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D 66:12–21
Pettersen EF, Goddard TD, Huang CCX, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE (2021) ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci 30:70–82
Schrödinger L, DeLano W (2020) PyMol. http://www.pymol.org/pymol
Stern AM, Yang Y, Jin S, Yamashita K, Meunier AL, Liu W, Cai Y, Ericsson M, Liu L, Goedert M et al (2023) Abundant Aβ fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer’s disease brains. Neuron 111:2012–2020
Yang Y, Zhang W, Murzin AG, Schweighauser M, Huang M, Lövestam S, Peak-Chew SY, Saito T, Saido TC, Macdonald J et al (2023) Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains. Acta Neuropathol 145:325–333
Article PubMed PubMed Central Google Scholar
Lövestam S, Schweighauser M, Matsubara T, Murayama S, Tomita T, Ando T, Hasegawa K, Yoshida M, Tarutani A, Hasegawa M et al (2021) Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy. FEBS Open Bio 11:999–1013
Article PubMed PubMed Central Google Scholar
Crooks EJ, Fu Z, Irizarry BA, Zhu X, Van Nostrand WE, Chowdhury S, Smith SO (2022) An electrostatic cluster guides Aβ fibril formation in cerebral amyloid angiopathy. BioRxiv 2022.12.22.521588
Scheres SHW, Ryskeldi-Falcon B, Goedert M (2023) Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids. Nature 621:701–710
Wagner J, Degenhardt K, Veit M, Louros N, Konstantoulea K, Skodras A, Wild K, Liu P, Obermüller U, Bansal V et al (2022) Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease. Nature 612:123–131
Article PubMed PubMed Central Google Scholar
Van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S et al (2023) Lecanemab in early Alzheimer’s disease. N Engl J Med 388:9–21
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks JD, Wessels AM, Shcherbinin S, Wang H, Serap Monkul Nery E et al (2023) Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ2 randomized clinical trial. JAMA 330:512–527
Jucker M, Walker LC (2023) Alzheimer’s disease: from immunotherapy to immunoprevention. Cell 186:4260–4270
Comments (0)